KARAKTERISTIK KLINIS PASIEN YANG MENERIMA TERAPI ARV DI RSUD KABUPATEN BULELENG

I Gusti Ngurah Putu Candra -  STIKES BULELENG, Indonesia
Dewi Aprelia Meriyani* -  STIKES BULELENG, Indonesia
Luh Putu Desy Puspaningrat -  STIKES BULELENG, Indonesia
Yopita Triguno -  STIKES BULELENG, Indonesia
Ni Kadek Ayu Tamara Widya Sari -  STIKES BULELENG, Indonesia

 

 

ABSTRAK

 

Latar Belakang Penyakit menular yang selalu memberikan dampak tidak hanya kesehatan tetapi social dan ekomoni adalha HIV/AIDS.

Tujuan untuk mendeskripsikan kondisi klinis dan dmeografi pasien yang menerima terapi ARV.

MetodePenelitian deskriptif dengan pendekatan secara kohort retrospektifmenggunakan data sekunder dari register kohort ARV dari tahun 2005-2015 (11 tahun terapi ARV). Analisis yang digunakan adalah analisis univariat menggunakan SPSS versi 17.

Hasil Karakteristik klinis dan demografi pada odha yang menerima terapi ARV yaitu 45,32% dalam kondisi ambulatory, 75.42% mendapatkan regimen NNRTI jenis zidovudine, 75.82 % mendapatkan terapi regimen NRTI nevirapine, 79.66% pada kondisi stadium 3 dan 4, dengan klasifikasi umur produktif (< 40 tahun sebanyak 82.05%, sebagian besar berjenis kelamin laki-laki 62.96%, dan memiliki pengawas minum obat (PMO) sebesar 68.25%. Proporsi kematian sebesar  9.3 % (112 orang), LTFU (loss to follow up) 18.52% (223 orang), subsitusi regimen lini satu 9.88% (119 orang),rujuk keluar 1.83% (22 orang) dan yang masih dalam pengobatan sebesar 69.93% (842).

Kesimpulan Pasien yang mengalami LTFU terbagi dalam beberapa kondisi yaitu LTFU dalam kondisi meninggal 3.07% (37 orang), LTFU dalam kondisi hidup 0.5% (6 orang), dan LTFU yang tidak diketahui kondisinya sebesar 14.95% (180 orang).

Saran Monitoring dan evaluasi pada program pengobatan dilakukan secara berkelanjutan untuk meningkatkan konsistensi terapi yang dilakukan.

 

 Kata Kunci : Karakteristik, Terapi, HIV/AIDS

 

  1. DAFTAR PUSTAKA
  2. Abyu, D. M., Getahun, E. A., Malaju, M. T., & Bizuayehu, H. M. (2014). Time to increase WHO clinical stage of people living with HIV in public health facilities of Arba Minch town, south Ethiopia. Clinical Medicine Research Direslgne Misker Abyu Clinical Medicine Research, 3(5), 119–124. https://doi.org/10.11648/j.cmr.20140305.11
  3. Adnyani, S., S., S., L., W., A., S., E.P., A., J., R., & N., W. (2016). Factors associated with zidovudine substitution in HIV/AIDS patients attending Badung Hospital, Bali, Indonesia between 2006-2014. International Journal of Research in Medical Sciences, 4(11), 5028–5033. https://doi.org/10.18203/2320-6012.ijrms20163812
  4. Bekolo, C. E., Webster, J., Batenganya, M., Sume, G. E., & Kollo, B. (2013a). Trends in mortality and loss to follow-up in HIV care at the Nkongsamba Regional hospital, Cameroon. BMC Research Notes. https://doi.org/10.1186/1756-0500-6-512
  5. Bekolo, C. E., Webster, J., Batenganya, M., Sume, G. E., & Kollo, B. (2013b). Trends in mortality and loss to follow-up in HIV care at the Nkongsamba Regional hospital, Cameroon. BMC Research Notes, 6(1), 512. https://doi.org/10.1186/1756-0500-6-512
  6. Brinkhof, M. W. G., Pujades-Rodriguez, M., & Egger, M. (2009). Mortality of patients lost to follow-up in antiretroviral treatment programmes in resource-limited settings: systematic review and meta-analysis. PloS One, 4(6), e5790. https://doi.org/10.1371/journal.pone.0005790
  7. Dewi, P. D. P. K., Agung, A., Sawitri, S., Putu, L., Wulandari, L., Putra, I. W. G. A. E., Ayu, P., Astuti, S., Januraga, P. P., Muliawan, P., Wirawan, D. N., & Mathers, B. (2015). SEX AND PARTNER STATUS AS PREDICTORS OF LOSS TO FOLLOW UP AMONG HIV / AIDS PATIENTS ON ARV TREATMENT IN BADUNG DISTRICT HOSPITAL , BALI 2006 - 2014. 2015.
  8. European, W. (n.d.). HIV / AIDS TREATMENT AND CARE Clinical protocols for the WHO European Region HIV / AIDS TREATMENT AND CARE Clinical protocols for the WHO European Region.
  9. Hawkins, C., Chalamilla, G., Okuma, J., Spiegelman, D., Hertzmark, E., Aris, E., Ewald, T., Mugusi, F., Mtasiwa, D., & Fawzi, W. (2011). Sex differences in antiretroviral treatment outcomes among HIV-infected adults in an urban Tanzanian setting. AIDS (London, England), 25(9), 1189–1197. https://doi.org/10.1097/QAD.0b013e3283471deb
  10. Kemenkes RI. (2011). Pedoman Nasional Tatalaksana Klinis Infeksi HIV dan Terapi Antiretroviral Pada Orang Dewasa.
  11. Lubega, M., Joshua, G., Dhafa, G., Badaza, R., Bakwesegha, C. J., & Reynolds, S. J. (2015). Sex inequality , high transport costs , and exposed clinic location : reasons for loss to follow-up of clients under prevention of mother-to-child HIV transmission in eastern Uganda – a qualitative study. 447–454.
  12. Mcmahon, J. H., Elliott, J. H., Hong, S. Y., Bertagnolio, S., & Jordan, M. R. (2013). Effects of Physical Tracing on Estimates of Loss to Follow- Up , Mortality and Retention in Low and Middle Income Country Antiretroviral Therapy Programs : A Systematic Review. 8(2). https://doi.org/10.1371/journal.pone.0056047
  13. Mitra, A., & Sarkar, D. (2011). Gender inequality and the spread of HIV‐AIDS in India. International Journal of Social Economics, 38(6), 557–572. https://doi.org/10.1108/03068291111131409
  14. Taylor-Smith, K., Tweya, H., Harries, A., Schoutene, E., & Jahn, A. (2010). Gender differences in retention and survival on antiretroviral therapy of HIV-1 infected adults in Malawi. Malawi Medical Journal : The Journal of Medical Association of Malawi, 22(2), 49–56. http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3345762&tool=pmcentrez&rendertype=abstract
  15. WHO. (2006). PATIENT MONITORING GUIDELINES FOR HIV CARE AND ANTIRETROVIRAL THERAPY ( ART ).
  16. WHO. (2007). HIV / AIDS Programme WHO CASE DEFINITIONS OF HIV FOR SURVEILLANCE AND REVISED CLINICAL STAGING AND IMMUNOLOGICAL CLASSIFICATION OF HIV-RELATED DISEASE IN ADULTS AND CHILDREN.
  17. WHO. (2013). Consulidated Guidelines on The Use Of Antiretroviral Drugs For Treating And Preventing HIV Infection Recommendations For A Public Health Approach. June.

Open Access Copyright (c) 2020 Jurnal Kebidanan Malahayati

Policies

Submissions

Other

Focus and Scope
Section Policies
Peer Review Process
Publication Frequency
Open Access Policy
Online Submissions
Author Guidelines
Copyright Notice
Privacy Statement
Author Fees
Journal Sponsorship
Journal History
Site Map
About this Publishing System
JKM (Jurnal Kebidanan Malahayati)